© 1994 by Oxford University Press
Journal of the National Cancer Institute, Vol. 86, No. 12, 913-920,
June 15, 1994
© 1994 Oxford University Press
Organ-Specific Modulation of Steady-State mdr Gene Expression and Drug Resistance in Murine Colon Cancer Cells
Department of Cell Biology, The University of Texas M. D. Anderson Cancer Center Houston, Tex
*Correspondence to: Isaiah J. Fidler, D.V.M., Ph.D., Department of Cell Biology, HMB 173, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030
Background: The major cause of death from cancer is metastases that are resistant to conventional therapies. The resistance of metastatic tumor cells to chemotherapy can be caused by their intrinsic properties, such as increased expression of the mdr genes. Purpose: The purpose of our present study was to determine some of the mechanisms by which the organ microenvironment influences the response of tumor cells to chemotherapy. Methods: Murine CT-26 colon cancer cells growing in continuous culture (parental cells) were harvested and injected subcutaneously into the lateral flank (to produce subcutaneous tumors) or the lateral tail vein (to produce experimental lung metastases) of 10 8-week-old syngeneic male BALB/c mice. Seven days after tumor-cell injection, the mice were given intravenous injections of either doxorubicin (10 mg/kg) or 0.9% NaCl (controls). This in vivo injection was repeated 7 days later. Mice with subcutaneous tumors and lung metastases were killed by cervical dislocation on day 21, and tumor samples from control mice were harvested and adapted to culture. The sensitivity of the cultured cells to doxorubicin and fluorouracil (5-FU) was determined at multiple time points. Levels of mdr-1 DNA were measured by slot-blot and Southern-blot analyses, mdr mRNA expression levels were measured by Northern-blot analysis using mdr-1- and mdr-3-specific hybridization probes, and P-glycoprotein level was determined by fluorescence-activated cell sorting using different monoclonal antibodies. Results: Treatment with doxorubicin produced 80% growth inhibition of CT-26 subcutaneous tumors but had little effect on the number (and size) of experimental lung metastases. Collectively, the results suggest that the multidrug-resistant phenotype developed in CT-26 cells growing in the lung environment. Cultures established from lung metastases were initially resistant to doxorubicin (but not to 5-FU) and showed elevated expression of mdr-1 mRNA transcripts and P-glycoprotein. This resistance could be overcome by verapamil and disappeared after 21 days in culture. No mdr gene amplification was detected. The expression level of mdr-specific mRNA (predominance of mdr-1) and P-glycoprotein was directly associated with resistance to doxorubicin. Conclusions: Results of this study have demonstrated that the in vivo sensitivity of murine CT-26 colon carcinoma cells to doxorubicin depends on the organ environment. The organ environment can influence the P-glycoprotein-mediated multidrug-resistant phenotype in tumor cells, and the increased expression of P-glycoprotein is transient; once removed from the environment (lung), the cell's resistance reverts to that of the sensitive parent cells. [J NatI Cancer Inst 86:913–920, 1994]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. V. Cespedes, C. Espina, M. A. Garcia-Cabezas, M. Trias, A. Boluda, M. T. Gomez del Pulgar, F. J. Sancho, M. Nistal, J. C. Lacal, and R. Mangues Orthotopic Microinjection of Human Colon Cancer Cells in Nude Mice Induces Tumor Foci in All Clinically Relevant Metastatic Sites Am. J. Pathol., March 1, 2007; 170(3): 1077 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Zhang, J. Lee, S. Lu, C. A. Pettaway, and Z. Dong Blockade of Transforming Growth Factor-{beta} Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude Mice Clin. Cancer Res., June 15, 2005; 11(12): 4512 - 4520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, Y.-W. Park, B. A. Schiff, D. D. Doan, Y. Yazici, S. A. Jasser, M. Younes, M. Mandal, B. N. Bekele, and J. N. Myers An Orthotopic Model of Anaplastic Thyroid Carcinoma in Athymic Nude Mice Clin. Cancer Res., March 1, 2005; 11(5): 1713 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hirasawa, S. G. Nishikawa, K. L. Norman, M. C. Coffey, B. G. Thompson, C.-S. Yoon, D. M. Waisman, and P. W. K. Lee Systemic Reovirus Therapy of Metastatic Cancer in Immune-competent Mice Cancer Res., January 15, 2003; 63(2): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zhang, W. Lu, and Z. Dong Tumor-infiltrating Macrophages Are Involved in Suppressing Growth and Metastasis of Human Prostate Cancer Cells by INF-{beta} Gene Therapy in Nude Mice Clin. Cancer Res., September 1, 2002; 8(9): 2942 - 2951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. FARRE, I. CASANOVA, S. GUERRERO, M. TRIAS, G. CAPELLA, and R. MANGUES Heterotopic implantation alters the regulation of apoptosis and the cell cycle and generates a new metastatic site in a human pancreatic tumor xenograft model FASEB J, July 1, 2002; 16(9): 975 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Zhang, G. Zhao, and Z. Dong Phosphatidylcholine-specific phospholipase C regulates activation of RAW264.7 macrophage-like cells by lipopeptide JBT3002 J. Leukoc. Biol., June 1, 2001; 69(6): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Ahmad, W. Liu, Y. D. Jung, F. Fan, M. Wilson, N. Reinmuth, R. M. Shaheen, C. D. Bucana, and L. M. Ellis The Effects of Angiopoietin-1 and -2 on Tumor Growth and Angiogenesis in Human Colon Cancer Cancer Res., February 1, 2001; 61(4): 1255 - 1259. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kuniyasu, W. Yasui, H. Shinohara, S. Yano, L. M. Ellis, M. R. Wilson, C. D. Bucana, T. Rikita, E. Tahara, and I. J. Fidler Induction of Angiogenesis by Hyperplastic Colonic Mucosa Adjacent to Colon Cancer Am. J. Pathol., November 1, 2000; 157(5): 1523 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Shaheen, D. W. Davis, W. Liu, B. K. Zebrowski, M. R. Wilson, C. D. Bucana, D. J. McConkey, G. McMahon, and L. M. Ellis Antiangiogenic Therapy Targeting the Tyrosine Kinase Receptor for Vascular Endothelial Growth Factor Receptor Inhibits the Growth of Colon Cancer Liver Metastasis and Induces Tumor and Endothelial Cell Apoptosis Cancer Res., November 1, 1999; 59(21): 5412 - 5416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pantel, R. J. Cote, and O. Fodstad Detection and Clinical Importance of Micrometastatic Disease J Natl Cancer Inst, July 7, 1999; 91(13): 1113 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. ZHU, N. L. BLOCK, and B. L. LOKESHWAR Interaction between Stromal Cells and Tumor Cells Induces Chemoresistance and Matrix Metalloproteinase Secretion Ann. N.Y. Acad. Sci., June 30, 1999; 878(1): 642 - 646. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Dong, J. Yoneda, R. Kumar, and I. J. Fidler Angiostatin-mediated Suppression of Cancer Metastases by Primary Neoplasms Engineered to Produce Granulocyte/Macrophage Colony-stimulating Factor J. Exp. Med., August 17, 1998; 188(4): 755 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Parker, B. J. Roseman, C. D. Bucana, R. Tsan, and R. Radinsky Preferential Activation of the Epidermal Growth Factor Receptor in Human Colon Carcinoma Liver Metastases in Nude Mice J. Histochem. Cytochem., May 1, 1998; 46(5): 595 - 602. [Abstract] [Full Text]
|
|